eMedicine CME

Home \| About eMedicine \| Contact Us

Enter your email address
to be notified when new
courses become available.

INTRODUCTION
eMedicine is pleased to offer this interactive series of free CME courses based on presentations recently given at cutting-edge national seminars and meetings by experts in the fields of Alzheimer's disease and dementia in general. These exciting new courses include multimedia slides, audio, video, and animations and provide up-to-date information on the evaluation, diagnosis, and treatment of Alzheimer's disease. All courses are accredited for up to 2 hours of AMA PRA category 1 credit.

AVAILABLE COURSES

This CME module is jointly sponsored by the American Association of Geriatric Psychiatry and eMedicine.
DESCRIPTION This slide and audio presentation (1) summarizes practical approaches that help detect and diagnose Alzheimer’s disease, (2) analyzes advances in brain imaging and what these techniques add to management, (3) reviews the rationale for emerging pharmacologic treatment strategies, and (4) discusses the latest advances in pharmacologic and nonpharmacologic treatment interventions and how these are best applied to daily clinical practice.

This CME module is jointly sponsored by the University of Medicine & Dentistry of New Jersey (UMDNJ), Department of Internal Medicine, UMDNJ Center for Continuing and Outreach Education and eMedicine.
DESCRIPTION Current estimates indicate that 50% of the AD population in the United States, approximately 2 million people, are not clinically diagnosed. Of those patients who are diagnosed, a vast number are not receiving pharmacologic therapy despite the known benefits of treatment. As the prevalence of AD is expected to reach 16 million by 2050, the need for better diagnostic measures and treatment initiation is further underscored. Using case studies to illustrate AD in the clinical setting, guidelines for the differential diagnosis of AD and utilization of available assessment tools will be presented in an effort to enhance AD diagnosis in clinical practice. Subsequent to diagnosis, treatment plans need to be developed individually for cognitively and functionally impaired patients. For this population, specific considerations, including polypharmacy and comorbidity, need to be addressed. These issues and known essential components of successful care plans will be discussed. Additionally, as patients continue to decline and new agents become available, pharmacologic treatments and treatment regimens require adjustments. Emerging treatment options and how to utilize them to optimize patient care will be discussed.